LUNG insider buying and SEC filings, explained
Pulmonx Corp · CIK 1127537
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- PULMONX
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$501K
Planned sales (10b5-1)
$46K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 1, 2026 | Sale | Srikanth Radhakrishnan (Chief Science & Techn. Officer) sold 14,245 shares at $2.26 ($32K). Holdings down 4% to 316,994 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 3, 2026 |
| Sep 1, 2026 | Sale | Glendon E. French III (CEO and Director) sold 41,882 shares at $2.26 ($95K). Holdings down 4% to 1,137,936 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 3, 2026 |
| Sep 1, 2026 | Sale | Geoffrey Beran Rose (Chief Commercial Officer) sold 7,879 shares at $2.26 ($18K). Holdings down 2% to 449,832 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 3, 2026 |
| Sep 1, 2026 | Sale | David Aaron Lehman (General Counsel) sold 14,334 shares at $2.26 ($32K). Holdings down 4% to 361,827 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 3, 2026 |
| Jun 1, 2026 | Sale | Srikanth Radhakrishnan (Chief Science &Techn. Officer) sold 14,497 shares at $1.54 ($22K). Holdings down 4% to 331,239 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 1–2, 2026 | Sale | Glendon E. French III (CEO and Director) sold 56,149 shares between Jun 1 and Jun 2 at about $1.55 ($87K). Holdings down 5% to 1,178,162 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 1, 2026 | Sale | Geoffrey Beran Rose (Chief Commercial Officer) sold 8,023 shares at $1.54 ($12K). Holdings down 2% to 457,711 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 1, 2026 | Sale | David Aaron Lehman (General Counsel) sold 14,594 shares at $1.54 ($22K). Holdings down 4% to 376,161 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Mar 2, 2026 | Sale | Srikanth Radhakrishnan (Chief Science &Techn. Officer) sold 10,483 shares at $1.43 ($15K). Holdings down 6% to 170,736 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Sale | Glendon E. French III (CEO and Director) sold 67,813 shares at $1.43 ($97K). Holdings down 5% to 1,409,511 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Sale | Geoffrey Beran Rose (Chief Commercial Officer) sold 7,732 shares at $1.43 ($11K). Holdings down 2% to 365,734 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Mar 2, 2026 | Sale | David Aaron Lehman (General Counsel) sold 12,237 shares at $1.43 ($17K). Holdings down 5% to 240,755 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 4, 2026 |
| Dec 8, 2025 | Planned (10b5-1) | Daniel P Florin (Director) sold 23,321 shares at about $1.99 ($46K), marked as a 10b5-1 plan trade. Holdings down 20% to 93,910 shares. | SEC filing Filed Dec 9, 2025 |
| Dec 1, 2025 | Sale | Glendon E. French III (CEO and Director) sold 8,805 shares at $1.57 ($14K). Holdings down 3% to 277,324 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
| Dec 1, 2025 | Sale | Geoffrey Beran Rose (Chief Commercial Officer) sold 6,322 shares at $1.57 ($10K). Holdings down 2% to 373,466 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
| Dec 1, 2025 | Sale | David Aaron Lehman (General Counsel) sold 10,278 shares at $1.57 ($16K). Holdings down 4% to 252,992 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
11 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LUNG in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.